The following provides a brief summary of medications available in Canada for acromegaly and whether they are covered by provincial pharmacare plans. While we have taken every step to keep this information up to date, it may have changed. Please consult with your medical team for the latest information and for the best treatment plan for you.
Produced by Novartis Pharmaceuticals.
Sandostatin LAR dosages available:
Typically one intramuscular injection every four weeks, administered by a medical professional.
New Brunswick Prescription Drug Program (NBPDP): covered as a general benefit; no special authorization required.
Information on the various patient support programs offered for these medications is available here.